# Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Study · id `cardio:ct-nct05893498` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05893498](<https://clinicaltrials.gov/study/NCT05893498>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05893498

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1924 participants.

## Technical summary

Registry record NCT05893498. Randomized; no masking; primary purpose diagnostic. Start 2023-06-21 (actual); primary completion 2026-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 1924 participants (planned count; ClinicalTrials.gov record NCT05893498, source copy `cardio:ctgov-nct05893498-2026-03-10`, retrieved 2026-10-26)
- Started: 2023-06-21 (actual) (ClinicalTrials.gov record NCT05893498, source copy `cardio:ctgov-nct05893498-2026-03-10`, retrieved 2026-10-26)
- Primary completion: 2026-05 (anticipated) (ClinicalTrials.gov record NCT05893498, source copy `cardio:ctgov-nct05893498-2026-03-10`, retrieved 2026-10-26)
- Completion: 2026-05 (anticipated) (ClinicalTrials.gov record NCT05893498, source copy `cardio:ctgov-nct05893498-2026-03-10`, retrieved 2026-10-26)
- Countries: United States; Israel; Japan; Switzerland; United Kingdom (ClinicalTrials.gov record NCT05893498, source copy `cardio:ctgov-nct05893498-2026-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05893498-2026-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
- Acronym: ALL-RISE
- Condition: Percutaneous Coronary Intervention
- Intervention (Device): FFRangio
- Intervention (Device): FFR or NHPR
- Lead sponsor: CathWorks Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Cardiovascular Research Foundation, New York
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Cardiovascular Research Foundation, New York (`cardio:org-cardiovascular-research-foundation-new-york`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Angiography-Derived Fractional Flow Reserve to Guide PCI (`cardio:pubmed-41910384`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e9d6cbed3a8b4c117b412069a5f5ea7560738d68bc59fc3bb40f3beeeae33a61
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
